Q&A: More Americans could benefit from Paxlovid for COVID infection

One of the best tools for preventing severe complications from COVID infection is the prescription antiviral drug Paxlovid. But not nearly as many people who could benefit from it are being prescribed it, says Amesh Adalja, MD, FIDSA, a senior scholar at the Johns Hopkins Center for Health Security who specializes in infectious diseases and pandemic preparedness.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart